Geneos Wealth Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
RC
PIM
WHG
Geneos Wealth Management's AVNS Position: Q3 2023 in Review
Geneos Wealth Management sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 25 shares — an estimated $639 sold.
Geneos Wealth Management first reported a position in AVNS in Q3 2018 and held it in 20 quarters. The position peaked at $91K in Q3 2018. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.
- Geneos Wealth Management reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
- Geneos Wealth Management sold 25 Avanos Medical shares in Q3 2023, an estimated $639.
- Geneos Wealth Management first reported a position in Avanos Medical in Q3 2018 and held it in 20 quarters.
- Geneos Wealth Management's Avanos Medical position peaked at $91K in Q3 2018.
- 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.
Based on Geneos Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.